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Abstract
Sudden unexplained death (SUD) is a sudden, unexpected, and unexplained death in an individual older than 1 year.
It is one of the most devastating and tragic events to families and the community at large, particularly when it happens at
a young age. Finding the cause of SUD is extremely important in order to prevent its recurrence in the family, and to help
understand the epidemiology of SUD in the community. It has been well-established that the most effective way of
ﬁnding the cause of SUD is by performing a medical autopsy. In many countries, medical autopsy is mandated in SUD
cases. In others, however, medical autopsy is rarely performed for the purpose of identifying the cause of SUD, which is
the case in Saudi Arabia. In this review, we discussed the importance of ﬁnding the cause of death in SUD cases, the role
of different types of medical autopsies, and the state of medical autopsy in Saudi Arabia. Moreover, we proposed a
clinical pathway to incorporate medical autopsy in the care of SUD cases, and to connect family members to the health
care system in order to perform cascade screening.
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1. Introduction

S

udden unexplained death (SUD) is a sudden,
unexpected, and non-traumatic death in an individual older than 1 year [1]. It is one of the most
devastating and tragic events to families and the
community at large, particularly when it happens at
a young age. Investigating SUD should be a public
priority due to the important implications for families (identiﬁcation of inherited conditions) and the
community (many years of potential life lost).
Beyond the value of “closure” to the grieving family,
ﬁnding the cause of SUD guides family screening
and informs preventative measures to prevent
further tragic events. Post-mortem autopsy is the
critical component of investigating SUD [1]. Indeed,

multiple studies have shown that autopsy identiﬁes
the cause of death in more than half of SUD victims
[2e5]. Moreover, when the autopsy is negative, it
narrows down the cause of death to a small number
of primary arrhythmic disorders (i.e., sudden
arrhythmic death syndrome, SADS), which could be
identiﬁed by genetic testing and/or family screening.
In Saudi Arabia, however, autopsies are seldom
performed for the purpose of identifying the cause of
SUDs [6]. This is despite the clear Fatwa from religious authority indicating that it’s permitted in
Islam. We intend in this review to discuss the
importance of medical autopsy in SUD, describe the
practice and challenges of performing autopsies in
Saudi Arabia, and suggest a pathway to implement
medical autopsy in the care of SUD victims.
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2. Epidemiology of SUD
Sudden cardiac death (SCD) in the elderly most
commonly occurs in the context of structural heart
disease. In contrast, however, SCD is often the
sentinel event in young adults and children with
inherited arrhythmia conditions (i.e., SUD). The
incidence of SCD in young adults and children is
estimated to be 1.3e8.5 per 100,000 patients-years
[4,7,8]. Limited data are available concerning the
epidemiology of SCD in Saudi Arabia. Nofal et al.
investigated a total of 1273 deaths at a university
hospital in Dammam and reported a prevalence of
SCD of 17.5%. Only 15% of them had a previous
diagnosis of a cardiovascular disease. Importantly,
15.2% of them were young adults and children aged
1e40 years old [9]. While this is likely a biased estimate given that it was collected in a hospital
setting, it provides some evidence suggesting that
SCD at young age is not a trivial problem in Saudi
Arabia, which should not be surprising given that
69% of the population is younger than 40 years of
age [10].
Causes of SCD are strongly inﬂuenced by age,
where coronary artery disease (CAD) is the most
common cause in individuals older than 50 years
old and rare for those younger than 35 years old [1].
Inherited arrhythmia conditions such as hypertrophic cardiomyopathy (HCM), arrhythmogenic right
ventricular cardiomyopathy (ARVC) and long QT
syndrome (LQTS) are the predominant cause of
SCD for younger individuals up to the age of 50year-old [2e4,7,11,12]. No studies have examined
the incidence or causes of SUD among Saudis.

3. The yield of invasive autopsy in identifying
the cause of death in SUD
An autopsy or a post-mortem examination (PME)
is a process used for the detection of causes of death
and other diseases. It is also a method to obtain
specimens for microbiological, electron microscopy,
molecular and genetic investigations. Death certiﬁcates are a major source of statistical data for identifying public health problems, monitoring progress
in public health, allocating research funds, and
conducting scientiﬁc research. Every effort must be
made to ensure that the most speciﬁc, accurate and
complete information regarding cause of death is
registered on death certiﬁcates.
Proper reporting of death certiﬁcates, and performing a PME when needed, is very effective in
ﬁnding the cause of death in the vast majority of
SUDs. While the yield of autopsy may vary from
study to study, most studies are able to identify the
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Catecholaminergic polymorphic ventricular
tachycardia
Implantable cardioverter-deﬁbrillator

cause of death or at least narrow it down to a limited
number of primary SADS causes [2e5]. For
example, Puranik et al. performed a retrospective
investigation of the cause of death of 427 sudden,
non-traumatic death cases aged 5e35 in Eastern
Sydney, Australia, and PME revealed the cause of
death in 67% of the cases [2]. Multiple retrospective
studies reported similar results, including studies
performed in Ontario, Canada and Ireland, which
reported a similar yield of 72% and 73% among SCD
cases, respectively [3,4].
A prospective cohort study by Olallo Sanchez
et al. revealed more details about the importance of
autopsy and the addition of further testing such as
molecular autopsy in identifying the cause of death
in SUD cases [5]. The study reported that a diagnosis was reached through a conventional autopsy
in 81.1% of cases, with the majority being caused by
cardiac issues (56.87%) [5]. Furthermore, the study
reported that adding molecular autopsy revealed
the cause of death in 40% of previously unexplained
cases [5].

4. Non-invasive autopsy: molecular autopsy
Molecular autopsy, also known as post-mortem
molecular testing, refers to the use of genetic analysis to probe SUD with negative-traditional autopsy,
usually caused by an underlying inherited arrhythmogenic cardiac disease [13]. The inheritance of
such diseases is mostly autosomal dominant, which
indicates a higher risk of SCD in direct family
members of the deceased [14]. Therefore, molecular
autopsy is crucial for identifying the underlying
pathogenic or likely pathogenic variants to help
detect risks in other family members and to help
prevent more sudden deaths in the family [13e15].
For an efﬁcient diagnosis, a multidisciplinary team
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including cardiologists, geneticists, forensic pathologists and psychologists, should be involved, as the
process of investigating a sudden death begins with
extracting DNA from blood or tissue collected at
autopsy, followed by next generation sequencing
and inclusive ﬁltering of variants based on cardiomyopathy and channelopathy genes, then prioritization of variants to assess pathogenicity through
bioinformatics pipelines [14e16].
Cann et al. analyzed 96 sudden cardiac death cases
over a 13 years period and was able to make a molecular diagnosis in 15% of SADS and 18% of cardiomyopathy deaths by deﬁning pathogenicity of
sequence variants integrating family phenotype information and population genomic data [16]. Similarly, Campuzano et al. studied 44 post-mortem
samples of infants who died suddenly with no deﬁnite cause of death after a complete autopsy. They
were able to identify 121 rare genetic variants, 33.05%
of them were novel and 39.66% were located in genes
encoding ion channels or associated proteins [17].
Both of which concluded that molecular autopsy
should be included in the forensic protocol when no
conclusive cause of death is known [16,17].
Molecular autopsy is also used by proxy, which
refers to the genetic testing (Whole Exome
Sequencing) of parents and relatives of the deceased
individual to presume the cause of death. Alghamdi
et al. found it to be a helpful approach to consanguineous couples who lost one or more children and/
or pregnancies with no DNA available from the
deceased ones for testing. This study was done on 83
consanguineous Saudi couples and was able to
molecularly inform genetic counseling in 43 out of 83
Saudi couples (52%) [18]. Similarly, molecular autopsy by proxy was done in 44 families with at least
one death or lethal fetal malformation, where pathogenic or likely pathogenic variants were identiﬁed
in 50% of the families and variants of uncertain signiﬁcance (VUS) were identiﬁed in 34% of the families. Shamseldin et al. concluded that molecular
autopsy by proxy is indeed a practical and high-yield
alternative to traditional autopsy [19].
Challenges and concerns regarding molecular autopsy differ from one country to the other. For
instance, in the United States of America, there is an
increasing shortage of qualiﬁed medical examiners
and medical insurance does not cover the cost of postmortem molecular testing [15]. In Switzerland and
other European countries, legal guidelines for genetic
testing do not address the use of molecular tools for
post-mortem genetic analyses in forensic practice
[20]. According to van Driel et al., ethical, legal and
ﬁnancial problems emerge with attempts to increase
genetic screening in the Netherlands, even after the

ﬁnding that 50% of families with SCD were diagnosed
with a cardiogenetic disorder [21]. In Saudi Arabia,
religion raises a major concern regarding autopsies,
even though dissection is allowed if it is legally
required [22]. Molecular autopsy offers a way to detect
the cause of death without disrupting the Islamic
principles. Although it is an important tool, the beneﬁts will be limited without a traditional autopsy in
SUDs and SCDS. Therefore, there is a need to reassess the policy regarding the performance of autopsies in our country [22].

5. Non-invasive autopsy: Virtual Autopsy
(virtopsy)
Virtual Autopsy (virtopsy) is a relatively new
method of performing an autopsy without the need
for invasive procedures. Instead, it uses radiological
techniques such as magnetic resonance imaging
(MRI) or multi-slice spiral computer tomography
(CT) in order to ﬁnd the cause of death. While virtopsy has not replaced conventional invasive autopsy worldwide, it is a very useful alternative for
performing an autopsy in countries with cultural
and religious barriers to conventional autopsy, such
as Saudi Arabia.
Since the use of virtopsy is not widespread, the
number of studies comparing the yield of virtopsy to
conventional autopsy is still limited. However, the
majority of the studies suggest that it is relatively
effective in ﬁnding the cause of death in a shorter
time and with less distress to the family of the
diseased [23e25]. For example, a prospective study
of 29 autopsy cases reported that a virtopsy was able
to reach the same conclusion as a conventional autopsy in two out of three cases [23]. Another study of
40 cases reported similar results with virtopsy
independently ﬁnding the cause of death in 55% of
the cases [24]. Most recently, the ﬁrst virtopsy in
Saudi Arabia was performed at King Khaled University Hospital and identiﬁed a radiologic ﬁndings
consistent with an autosomal recessive polycystic
kidney disease (ARPKD), which was conﬁrmed by
conventional autopsy [25].
The yield of a virtopsy can be improved signiﬁcantly by the addition of CT-guided biopsies to the
radiological testing, and this process is known as a
minimally invasive autopsy. A prospective cohort
study showed that while the yield of a standalone
CT or MRI was limited, the use of a minimally
invasive autopsy provided the answer to 84.5% of
the cases [26]. Therefore, the use of minimally
invasive autopsy could be a very effective and
publicly acceptable way of performing an autopsy in
Saudi Arabia.

6. The clinical value of autopsy in preventing
SCD in family members
Performing an autopsy in individuals with SUD is
strongly recommended by the recent guidelines [1].
This is because it guides the next step in the management of ﬁrst-degree relatives. When the autopsy
identiﬁes the cause of SUD, clinical investigation
will focus on screening the family for that speciﬁc
cause, which is helpful because some of these conditions require expensive investigation (e.g., cardiac
magnetic resonance for ARVC) or have a variable
age presentation (e.g., HCM and ARVC) and as such
need repeat testing. Even when the autopsy is
negative (i.e., SADS), autopsy remains helpful as it
narrows down the causes of death to a small number of primary arrhythmic conditions such as LQTS,
Brugada
syndrome,
and
Catecholaminergic
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polymorphic ventricular tachycardia (CPVT). As
such, the strategy by which we approach ﬁrst degree
relatives of a SUD victim is highly dependant on the
results of the autopsy.
Because most of the causes of SUD at young age
are related to inherited arrhythmia conditions, the
primary goal of family screening is to identify these
conditions to potentially prevent SCD in affected
family members. This is particularly relevant given
the available effective therapies for most of the
conditions such as beta-blockers for LQTS and
CPVT, and implantable cardioverter-deﬁbrillator
(ICD) for HCM. Also, important lifestyle modiﬁcations can modify the prognosis of some of these
conditions and potentially prevent SCD, such as
aggressive fever treatment in Brugada syndrome
and avoidance of competitive sports in ARVC and
HCM. Even when the cause of SUD is not a clearly

Fig. 1. Proposed pathway for medical autopsy: SUD: sudden unexplained death. * SUD criteria: 1- Death occurring within an hour of onset of
symptoms, or in patients found dead within 24h of being asymptomatic, 2- Unexplained by previous SCD-predisposing condition, toxin, homicide, or
suicide. ** Inherited arrhythmia clinics are multidisciplinary clinics with a team including an electrophysiologist, medical geneticist, genetic
counsellor, and a pathologist.
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inherited condition (i.e., not a monogenic condition)
such as early-onset CAD, there is likely a value of
early diagnosis and aggressive treatment of risk
factors in preventing SCD, given that these families
are at higher risk of SCD due to CAD [27].

7. The state of medical autopsy in Saudi
Arabia
Autopsies in most Muslim nations including
Saudi Arabia, are performed by the department of
forensic medicine under the direction of Ministry of
Interior. Because of the perceived disﬁgurations, the
medical environment is generally opposed to autopsy. A recent survey of 234 Saudi physicians and
interns found that while most physicians (86.32%)
think that an autopsy is important to perform,
almost all of them (98.29%) have never taken part in
an autopsy and only 4% were offered a chance to
attend an autopsy session [28]. Moreover, the study
reported that the main barriers to performing an
autopsy were respect for the religious beliefs of the
families of the deceased and respect for family
mourning [28]. In the last several years after establishing a Saudi speciality training program, forensic
medical education in Saudi Arabia expanded.
However, both the system and training program
focus on homicide and suspicious for homicide
cases. There is no system for medical autopsies and
no training program that trains pathologists to do
medical autopsy [6,25]. As a result, there is no system in Saudi Arabia for medical autopsies of natural
deaths, although preliminary acceptance of this
service is pending at the college of Medicine, King
Saud University, following the Centers for Disease
Control and College of American Pathologists
guidelines [29].

8. Proposed pathway for autopsy in SUD cases
in Saudi Arabia
Performing a medical autopsy is the cornerstone
of ﬁnding the cause of SUD. It can facilitate family
screening with the ultimate goal of preventing SCD
in these families. There is an urgent need to establish a clear pathway to implement medical autopsy
for SUD cases in Saudi Arabia. Fig. 1 shows our
proposed pathway to include medical autopsy for
SUD and link family members to the health care
system in order to perform cascade screening. The
pathway starts when a natural death occurs, and a
death report is written. We suggest adding a questionnaire that screens the case for SUD by checking
for the following SUD criteria: 1- Death occurring
within an hour of onset of symptoms, or in patients

found dead within 24h of being asymptomatic, 2Death is not due to homicide, suicide or explained
by an established SCD-predisposing condition or a
toxicology screen. If the case fulﬁls the criteria, the
next of kin are offered the following options: conventional autopsy or virtopsy/minimally invasive
autopsy (þ/-molecular autopsy). After performing
the chosen autopsy, the autopsy report is sent to the
family physician of the next of kin and the family are
consulted about the cause of death. Then, all ﬁrst
degree relatives are referred to a specialized and
multidisciplinary clinic (inherited arrhythmia clinic)
which includes a cardiologist, medical geneticist,
genetic counsellor and a pathologist, where a complete evaluation will be performed. This will obviously require a network of clinics and a collaboration between death affairs departments and these
clinics.

9. Conclusion
SUD is a devastating event and one that needs
thorough investigation in order to prevent its recurrence in the family. There is no system in place in
Saudi Arabia to perform medical autopsy and family
screening in SUD cases. Our review calls for an urgent change to implement routine medical autopsy
and family screening with the ultimate goal of preventing SCD in affected families. In addition, we
proposed a clinical pathway to enable these services.
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